跳至主要内容
临床试验/NCT06357923
NCT06357923招募中不适用

Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance as Well as Variations and Allelic Mutations in the Main Genes Involved in the Occurrence of Age-related Myelodysplastic Syndromes

Centre Hospitalier Universitaire de Nice1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Expression level of LAMP2 (protein and isoform A and B mRNA)

研究概览

简要总结

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1.

详细描述

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1. After explanations and collection consent, collection of the patient's socio-demographic and medical characteristics and then carrying out a Peripheral venous blood sample (2 x 5ml tubes).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
60 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Men and women over 60 years of age.

排除标准

  • •Inability to Understand Consent,
  • •Non-Security Beneficiaries
  • •social, subjects protected by law, subjects deprived of liberty,
  • •history of breast cancer,
  • •brain tumor,
  • •melanoma,
  • •colon cancer,
  • •lung cancer,
  • •prostate cancer,
  • •lymphoma,
  • •syndrome myelodysplastic/myeloproliferative,
  • •leukemia,
  • •history of radiation therapy.

研究组 & 干预措施

evaluation of LAMP-2 protein expression

Other

dosing of level expression of LAMP-2

干预措施: dosage (Diagnostic Test)

结局指标

主要结局

Expression level of LAMP2 (protein and isoform A and B mRNA)

时间窗: day 0

dosage

次要结局

  • Presence of mutation in the "Oncomin Myeloid Reasearch Assay" gene panel targeting approximately 40 Different genes(day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验